Market Cap (In CNY)
5.41 Billion
Revenue (In CNY)
663.02 Million
Net Income (In CNY)
176.11 Million
Avg. Volume
3.05 Million
- Currency
- CNY
- Country
- Basic Materials
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 13.63-25.77
- PE
- -
- EPS
- -
- Beta Value
- 0.981
- ISIN
- CNE100005782
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Mr. Qun Liang
- Employee Count
- -
- Website
- https://biocause.com
- Ipo Date
- 2021-12-22
- Details
- Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.
More Stocks
-
FBU
-
ONPHOncology Pharma Inc.
ONPH
-
S32South32 Limited
S32
-
002350
-
SBLI
-
300762Jushri Technologies, INC.
300762
-
3013
-
EROEro Copper Corp.
ERO